N'-((2-Chloro-7-methylquinolin-3-yl)methylene)cyclohexanecarbohydrazide

Catalog No. :
ACUFNG251
CAS No. :
477733-50-9
Molecular Formula :
C18H20ClN3O
Molecular Weight :
329.83

IUPAC Name:(E)-N'-((2-chloro-7-methylquinolin-3-yl)methylene)cyclohexanecarbohydrazide

N'-((2-Chloro-7-methylquinolin-3-yl)methylene)cyclohexanecarbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-((2-Chloro-7-methylquinolin-3-yl)methylene)cyclohexanecarbohydrazide
IUPAC Name(E)-N'-((2-chloro-7-methylquinolin-3-yl)methylene)cyclohexanecarbohydrazide
MDL No.MFCD03934553
Molecular FormulaC18H20ClN3O
Molecular Weight329.83
SMILESO=C(C1CCCCC1)N/N=C/C2=CC3=CC=C(C)C=C3N=C2Cl
InChI KeyPJDDYGTUTNRORA-RGVLZGJSSA-N
SynonymN'-((2-CHLORO-7-METHYL-3-QUINOLINYL)METHYLENE)CYCLOHEXANECARBOHYDRAZIDE;SALOR-INT L240249-1EA;N'-((2-CHLORO-7-METHYL-3-QUINOLINYL)METHYLENE)CYCLOHEXANECARBOHYDRAZIDE
CAS No.477733-50-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUFNG251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTESM498 route compound structure diagram
    ACTESM49868236-21-5 In Stock
  2. Plus
  3. ACIGJH823 route compound structure diagram
    ACIGJH82338941-47-8 In Stock
  4. Then
  5. ACUFNG251 route product structure diagram
    ACUFNG251477733-50-9
Inquiry

2. ACUFNG251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUFNG251 route product structure diagram
    ACUFNG251477733-50-9
Inquiry

Comments (0)